Literature DB >> 15735224

Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.

Maximilian von Eynatten, Jochen G Schneider, Senad Hadziselimovic, Andreas Hamann, Angelika Bierhaus, Peter P Nawroth, Klaus A Dugi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735224     DOI： 10.2337/diacare.28.3.754

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  15 in total

1.  Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study.

Authors:  C Menzaghi; S De Cosmo; M Copetti; L Salvemini; C De Bonis; D Mangiacotti; G Fini; F Pellegrini; V Trischitta
Journal:  Diabetologia       Date:  2011-01-13       Impact factor: 10.122

2.  Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.

Authors:  Yuji Takahashi; Mamoru Satoh; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  Heart Vessels       Date:  2011-06-04       Impact factor: 2.037

3.  Pharmacological effects of lipid-lowering drugs on circulating adipokines.

Authors:  Desiree Wanders; Eric P Plaisance; Robert L Judd
Journal:  World J Diabetes       Date:  2010-09-15

4.  Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes.

Authors:  C-H Chu; J-K Lee; H-C Lam; C-C Lu; C-C Sun; M-C Wang; M J Chuang; M-C Wei
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

5.  Role of leptin in atherogenesis.

Authors:  Laxman Dubey; Zeng Hesong
Journal:  Exp Clin Cardiol       Date:  2006

6.  Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis.

Authors:  Veronica De Rosa; Claudio Procaccini; Antonio La Cava; Paolo Chieffi; Giovanni Francesco Nicoletti; Silvia Fontana; Serafino Zappacosta; Giuseppe Matarese
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

7.  Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Anna Gotzamani-Psarrakou; Triantafillos P Didangelos; John G Yovos; Dimitrios T Karamitsos
Journal:  Open Cardiovasc Med J       Date:  2011-06-20

8.  Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.

Authors:  Claudia Menzaghi; Lucia Salvemini; Grazia Fini; Ryan Thompson; Davide Mangiacotti; Rosa Di Paola; Eleonora Morini; Maddalena Giorelli; Concetta De Bonis; Salvatore De Cosmo; Alessandro Doria; Vincenzo Trischitta
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

9.  Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Authors:  Panayoula C Tsiotra; Constantine Tsigos; Eleni Anastasiou; Eleni Yfanti; Eleni Boutati; Emmanouil Souvatzoglou; Ioannis Kyrou; Sotirios A Raptis
Journal:  Mediators Inflamm       Date:  2008-12-21       Impact factor: 4.711

10.  Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

Authors:  Claudia Menzaghi; Simonetta Bacci; Lucia Salvemini; Christine Mendonca; Giuseppe Palladino; Andrea Fontana; Concetta De Bonis; Antonella Marucci; Elizabeth Goheen; Sabrina Prudente; Eleonora Morini; Stefano Rizza; Alyssa Kanagaki; Grazia Fini; Davide Mangiacotti; Massimo Federici; Salvatore De Cosmo; Fabio Pellegrini; Alessandro Doria; Vincenzo Trischitta
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.